Skip to main content
Signal8
MERRIFIELD C ANN profile photo

C. Ann Merrifield

CIK: 0001247224

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Lyra Therapeutics, Inc. logo
LYRA

Lyra Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Lyra Therapeutics, Inc. logo
    LYRA

    Lyra Therapeutics, Inc.

    May 14, 2025
    Award(A)

    Restricted Stock Units

    Direct
    32K shares-

1-1 of 1

C. Ann Merrifield files insider reports with the SEC as Director of Lyra Therapeutics, Inc. (LYRA). Signal8 holds 1 reported Form 4/5 transaction by C. Ann Merrifield since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in LYRA, dated May 14, 2025.

About MERRIFIELD C ANN

MERRIFIELD C ANN (SEC CIK 0001247224) files insider reports with the SEC as Director of Lyra Therapeutics, Inc. (LYRA).

Signal8 holds 1 ownership filing by MERRIFIELD C ANN, a Form 4, filed on May 16, 2025. Those filings report 1 transaction, the latest on May 14, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on MERRIFIELD C ANN's filings is in WATERTOWN, MA.

Recent filings by MERRIFIELD C ANN

  • May 14, 2025: Grant or award of LYRA derivative securities (Form 4, code A).

Other insiders filing for Lyra Therapeutics, Inc. (LYRA)

How to read Form 4 transaction codes